schizophrenia. Paranoid schizophrenia
Conditions
Interventions
Case group:Tab Aspirin 500 mg ,BID( Abidi company)
Intervention 1: Case group:Tab Aspirin 500 mg ,BID( Abidi company). Intervention 2: placebo group: tab placebo Aspirin like 500 mg ,BID.
Placebo
Treatment - Drugs
placebo group: tab placebo Aspirin like 500 mg ,BID
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1 - Is based on DSM-IV diagnosis of schizophrenia. 2 - The patient or patient's guardian consent to participate. 3 - PANSS score at the beginning of the project is more than 60. 4 - less than 5 years of disease duration and between 3 to 1 episodes. 5 - No physical disease based on clinical examination. 6 - Chronic NSAID is not used. 7 - Not taking corticosteroids. 8 - Not pregnant. 9 - there is no contraindication for aspirin and omeprazole. Exclusion criteria: 1 - Sensitivity to the drug 2 - Patients who choose to be excluded. 3 – Require other drugs. (Anticholinergics and benzodiazepines are excepted) 4 – Where ECT is needed.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive disorders. Timepoint: baseline and 3th,6th,12th weeks. Method of measurement: cognition tests.;Clinical symptoms. Timepoint: baseline and 3th,6th,12th weeks. Method of measurement: PANSS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam Tavakoli
Psychiatric Ibnesina Hospital
Outcome results
None listed